MERRIMACK PHARMACEUTICALS INC Long-Term Debt, Maturity, Year Two
MERRIMACK PHARMACEUTICALS INC had Long-Term Debt, Maturity, Year Two of $8.39 million as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2019-05-10
- 2019-03-31: Long-Term Debt, Maturity, Year Two $8.39M.
- 2018-12-31: Long-Term Debt, Maturity, Year Two $8.40M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2019-03-31 | $8.39M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $8.40M 10-K · filed 2019-03-06 |